Literature DB >> 31391931

PRO: Patients With Decompensated Cirrhosis Listed for Liver Transplantation Should Be Treated Pretransplant.

Tete Ukpong1, Parvez Mantry2.   

Abstract

Entities:  

Year:  2019        PMID： 31391931      PMCID： PMC6677009          DOI： 10.1002/cld.808

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  11 in total

1.  Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.

Authors:  David Goldberg; Ivo C Ditah; Kia Saeian; Mona Lalehzari; Andrew Aronsohn; Emmanuel C Gorospe; Michael Charlton
Journal:  Gastroenterology       Date:  2017-01-11       Impact factor: 22.682

2.  Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial.

Authors:  Michael Manns; Didier Samuel; Edward J Gane; David Mutimer; Geoff McCaughan; Maria Buti; Martín Prieto; José Luis Calleja; Markus Peck-Radosavljevic; Beat Müllhaupt; Kosh Agarwal; Peter Angus; Eric M Yoshida; Massimo Colombo; Mario Rizzetto; Hadas Dvory-Sobol; Jill Denning; Sarah Arterburn; Phillip S Pang; Diana Brainard; John G McHutchison; Jean-François Dufour; Hans Van Vlierberghe; Bart van Hoek; Xavier Forns
Journal:  Lancet Infect Dis       Date:  2016-02-18       Impact factor: 25.071

3.  Controversies in Liver Transplantation.

Authors:  James F Trotter
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-02

Review 4.  Treatment strategies for chronic hepatitis C prior to and following liver transplantation.

Authors:  Ryan B Perumpail; Thomas A Hahambis; Avin Aggarwal; Zobair M Younossi; Aijaz Ahmed
Journal:  World J Hepatol       Date:  2016-01-08

5.  Optimal timing of hepatitis C treatment for patients on the liver transplant waiting list.

Authors:  Jagpreet Chhatwal; Sumeyye Samur; Brian Kues; Turgay Ayer; Mark S Roberts; Fasiha Kanwal; Chin Hur; Drew Michael S Donnell; Raymond T Chung
Journal:  Hepatology       Date:  2017-01-06       Impact factor: 17.425

Review 6.  The American College of Preventive Medicine Position Statement on Hepatitis C Virus Infection.

Authors:  Robert D Allison; Steven A Hale; Bart J Harvey; Toni-Marie L Hudson; Catherine J Livingston; Kevin M Sherin; Kelechi A Uduhiri; David W Niebuhr
Journal:  Am J Prev Med       Date:  2016-03       Impact factor: 5.043

7.  Hepatitis C Virus and Liver Transplantation.

Authors:  Kalyan Ram Bhamidimarri; Sanjaya K Satapathy; Paul Martin
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-04

Review 8.  Antiviral therapy in HCV-infected decompensated cirrhotics.

Authors:  Fazal A Danish; Salman S Koul; Fazal R Subhani; Ahmed E Rabbani; Saeeda Yasmin
Journal:  Saudi J Gastroenterol       Date:  2010 Oct-Dec       Impact factor: 2.485

9.  Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post-liver transplantation recurrence.

Authors:  Fred Poordad; Eugene R Schiff; John M Vierling; Charles Landis; Robert J Fontana; Rong Yang; Fiona McPhee; Eric A Hughes; Stephanie Noviello; Eugene S Swenson
Journal:  Hepatology       Date:  2016-03-07       Impact factor: 17.425

10.  Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis.

Authors:  Michael P Curry; Jacqueline G O'Leary; Natalie Bzowej; Andrew J Muir; Kevin M Korenblat; Jonathan M Fenkel; K Rajender Reddy; Eric Lawitz; Steven L Flamm; Thomas Schiano; Lewis Teperman; Robert Fontana; Eugene Schiff; Michael Fried; Brian Doehle; Di An; John McNally; Anu Osinusi; Diana M Brainard; John G McHutchison; Robert S Brown; Michael Charlton
Journal:  N Engl J Med       Date:  2015-11-16       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.